The iCMLf is sharing a selection of interesting scientific publications on COVID-19 and CML from peer-reviewed journals.

Latest publications on COVID-19 and Cancer/CML

March 2021

• COVID-19 in chronic-phase chronic myeloid leukemia patients: A single-center survey from Turkey
  Yilmaz U et al. Turk J Haematol, February 2021 – open access publication
• Blurring of vision as the only symptom of undiagnosed case of chronic myeloid leukemia in the COVID-19 era
  Gumaste P and Vairagyam R. Indian J Ophthalmol, March 2021 – open access publication
• Mild clinical course of COVID-19 infection in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitors (TKI’s) without interruption
  Demeter J et al. Mediterr J Hematol Infect Dis, March 2021 – open access publication
• COVID-19 in patients with haematological malignancies: Considering the role of tyrosine kinase inhibitors
  Morale-Ortega A et al. Cancer, March 2021 (epub ahead of print) – open access publication
  
• Reply to COVID-19 in patients with haematological malignancies: Considering the role of tyrosine kinase inhibitors
  Cattaneo C et al. Cancer, March 2021 (epub ahead of print) – open access publication
  
• Clinical presentations and outcomes of children with cancer and COVID-19: A systematic review
  Prasad Meena J et al. Pediatr Blood Cancer, March 2021 (epub ahead of print) – open access publication
• Challenges and opportunities for COVID-19 vaccines in patients with cancer
  Kuderer NM et al. Cancer Invest, March 2021

February 2021

• Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19
  Jacobs CF et al. Blood Adv, February 2021 - open access publication
• ASH registry offers insights on COVID-19 in patients with haematological malignancies
  Oncologist, February 2021 – open access publication
• Reduction in the rate and improvement in the prognosis of COVID-19 in haematological patients over time
  Cattaneo C et al. Leukemia, February 2021 – open access publication
• Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited
  Ribas A et al. Cancer Discov, February 2021
• Cancer patients and COVID-19: Mortality, serious complications, biomarkers, and ways forward
  Gupta K et al. Cancer Treat Res Commun 2021 - open access publication

January 2021

• COVID-19 induced Pancytopenia in a major molecular response CML patient on dasatinib: A case report and review of the literature
  Singh B et al. Eur J Case Rep Intern Med, January 2021 – open access publication
  
• Lymphopenia as a biological predictor of outcomes in COVID-19 patients: A Nationwide Cohort Study
  Lee J et al. Cancers(Basel), January 2021 – open access publication

Find more papers on COVID-19 and cancer/CML here

Latest publications on COVID-19

February 2021

• Efficacy and safety of the mRNA-1273 SARS-CoV2 vaccine
  Baden LR et al. N Eng J Med, February 2021 – open access publication
• COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies
  Rawat K et al. Eur J Pharmacol, February 2021 – open access publication
• What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV2
  Hodgson SH et al. Lancet Infect Dis, February 2021 – open access publication

November 2020

• COVID-19: A review of the proposed pharmaceutical treatments
  Lam S et al. Eur J Pharmacol, November 2020 – open access publication

October 2020

• Possible therapeutic agents for COVID-19: a comprehensive review
  Elhusseiny KM et al. Expert Rev Anti Infect Ther, October 2020 – open access publication

September 2020

• A living WHO guideline on drugs for COVID-19
  Lamontagne F et al. BMJ, September 2020
• Vaccines for COVID-19
  Tregoning JS. Clin Exp Immunol, September 2020 – open access publication

Find more papers on COVID-19 here